Your Health, We Care
Rezurock is indicated for the treatment of adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy.
from FDA，2024.04
What is the mechanism of action of belumosudil?Belumosudil is a prescription med···【more】
Release date：2026-04-07Recommended：36
Unique Immune Modulating Mechanism of BelumosudilChronic GVHD is characterized b···【more】
Release date：2026-04-02Recommended：54
iIndicated for the treatment of adult and pediatric patients 12 years and older ···【more】
Release date：2026-01-05Recommended：30
